Logo image of LTCH

LATCH INC (LTCH) Stock Fundamental Analysis

NASDAQ:LTCH - US51818V1061 - Common Stock

0.8238 USD
-0.08 (-9.15%)
Last: 8/9/2023, 8:22:58 PM
0.8226 USD
0 (-0.15%)
After Hours: 8/9/2023, 8:22:58 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to LTCH. LTCH was compared to 282 industry peers in the Software industry. No worries on liquidiy or solvency for LTCH as it has an excellent financial health rating, but there are worries on the profitability. LTCH does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year LTCH has reported negative net income.
LTCH had a negative operating cash flow in the past year.
LTCH Yearly Net Income VS EBIT VS OCF VS FCFLTCH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 -50M -100M -150M

1.2 Ratios

The profitability ratios for LTCH are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LTCH Yearly ROA, ROE, ROICLTCH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 -10 -20 -30 -40

1.3 Margins

LTCH does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LTCH Yearly Profit, Operating, Gross MarginsLTCH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 -100 -200 -300 -400

More info and screens

7

2. Health

2.1 Basic Checks

LTCH does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LTCH has more shares outstanding
There is no outstanding debt for LTCH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LTCH Yearly Shares OutstandingLTCH Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 50M 100M
LTCH Yearly Total Debt VS Total AssetsLTCH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of -0.48, we must say that LTCH is in the distress zone and has some risk of bankruptcy.
LTCH's Altman-Z score of -0.48 is on the low side compared to the rest of the industry. LTCH is outperformed by 75.54% of its industry peers.
LTCH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.48
ROIC/WACCN/A
WACC10.92%
LTCH Yearly LT Debt VS Equity VS FCFLTCH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 0 100M -100M 200M 300M

2.3 Liquidity

LTCH has a Current Ratio of 7.98. This indicates that LTCH is financially healthy and has no problem in meeting its short term obligations.
LTCH has a Current ratio of 7.98. This is amongst the best in the industry. LTCH outperforms 92.09% of its industry peers.
A Quick Ratio of 7.51 indicates that LTCH has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 7.51, LTCH belongs to the best of the industry, outperforming 91.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.98
Quick Ratio 7.51
LTCH Yearly Current Assets VS Current LiabilitesLTCH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 100M 200M 300M

More info and screens

3

3. Growth

3.1 Past

LTCH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -875.93%.
EPS 1Y (TTM)-875.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.39%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%105.99%

3.2 Future

LTCH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.09% yearly.
LTCH is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 73.98% yearly.
EPS Next Y5.99%
EPS Next 2Y9.71%
EPS Next 3Y7.09%
EPS Next 5YN/A
Revenue Next Year91.26%
Revenue Next 2Y91.29%
Revenue Next 3Y73.98%
Revenue Next 5YN/A

3.3 Evolution

LTCH Yearly Revenue VS EstimatesLTCH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 50M 100M 150M 200M
LTCH Yearly EPS VS EstimatesLTCH Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LTCH. In the last year negative earnings were reported.
Also next year LTCH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LTCH Price Earnings VS Forward Price EarningsLTCH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LTCH Per share dataLTCH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.71%
EPS Next 3Y7.09%

More info and screens

0

5. Dividend

5.1 Amount

LTCH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LATCH INC

NASDAQ:LTCH (8/9/2023, 8:22:58 PM)

After market: 0.8226 0 (-0.15%)

0.8238

-0.08 (-9.15%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-24 2023-07-24
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change9473.2%
Ins Owners8.91%
Ins Owner Change0%
Market Cap143.63M
Analysts85
Price Target5.61 (580.99%)
Short Float %0.21%
Short Ratio0.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.15%
Min EPS beat(2)-9.61%
Max EPS beat(2)7.31%
EPS beat(4)2
Avg EPS beat(4)-77.86%
Min EPS beat(4)-313.01%
Max EPS beat(4)7.31%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.78%
Min Revenue beat(2)-3.4%
Max Revenue beat(2)4.97%
Revenue beat(4)2
Avg Revenue beat(4)-1.66%
Min Revenue beat(4)-12.23%
Max Revenue beat(4)4.97%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)29.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.97
P/FCF N/A
P/OCF N/A
P/B 0.42
P/tB 0.44
EV/EBITDA N/A
EPS(TTM)-1.53
EYN/A
EPS(NY)-0.99
Fwd EYN/A
FCF(TTM)-0.92
FCFYN/A
OCF(TTM)-0.86
OCFYN/A
SpS0.28
BVpS1.96
TBVpS1.88
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.98
Quick Ratio 7.51
Altman-Z -0.48
F-Score5
WACC10.92%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-875.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.39%
EPS Next Y5.99%
EPS Next 2Y9.71%
EPS Next 3Y7.09%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%105.99%
Revenue Next Year91.26%
Revenue Next 2Y91.29%
Revenue Next 3Y73.98%
Revenue Next 5YN/A
EBIT growth 1Y-16407%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-24.36%
EBIT Next 3Y6.57%
EBIT Next 5YN/A
FCF growth 1Y-17828.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-16449.4%
OCF growth 3YN/A
OCF growth 5YN/A